We are live on ! Find out more
HighTower Advisors

HighTower Advisors Portfolio holdings

AUM $94.2B
1-Year Est. Return 21.24%
This Fund
S&P 500
This Quarter Est. Return
-11.65%
1 Year Est. Return
+21.24%
3 Year Est. Return
+66.34%
5 Year Est. Return
+83.36%
10 Year Est. Return
+290.31%
AUM
$13B
AUM Growth
-$835M
Cap. Flow
+$1.04B
Cap. Flow %
7.95%
Top 10 Hldgs %
17.44%
Holding
2,478
New
199
Increased
850
Reduced
902
Closed
277

Sector Composition

Rank Sector Weight
1 Technology 10.06%
2 Healthcare 9.47%
3 Financials 8.84%
4 Energy 7.17%
5 Industrials 6.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HMC icon
1451
Honda
HMC
$36.5B
$414K ﹤0.01%
15,636
-2,180
-12% -$60.3K
PWZ icon
1452
Invesco California AMT-Free Municipal Bond ETF
PWZ
$1.14B
$414K ﹤0.01%
16,044
-318
-2% -$8.08K
UDOW icon
1453
ProShares UltraPro Dow 30
UDOW
$849M
$414K ﹤0.01%
23,200
+6,528
+39% +$148K
AMG icon
1454
Affiliated Managers Group
AMG
$9.46B
$411K ﹤0.01%
4,228
-1,915
-31% -$216K
FANG icon
1455
Diamondback Energy
FANG
$57.6B
$411K ﹤0.01%
+4,403
New +$492K
EA icon
1456
Electronic Arts
EA
$52.4B
$410K ﹤0.01%
5,200
-3,863
-43% -$354K
JBGS
1457
JBG SMITH
JBGS
$846M
$410K ﹤0.01%
11,763
+1,007
+9% +$37.9K
PII icon
1458
Polaris
PII
$4.15B
$408K ﹤0.01%
5,292
-2,088
-28% -$188K
VIOG icon
1459
Vanguard S&P Small-Cap 600 Growth ETF
VIOG
$1.04B
$407K ﹤0.01%
5,860
RVNC
1460
DELISTED
Revance Therapeutics, Inc.
RVNC
$403K ﹤0.01%
20,000
-2,000
-9% -$44.1K
CRON
1461
Cronos Group
CRON
$1.05B
$402K ﹤0.01%
38,713
+12,189
+46% +$117K
AKAM icon
1462
Akamai
AKAM
$16.8B
$401K ﹤0.01%
6,563
-89
-1% -$5.92K
CCEP icon
1463
Coca-Cola Europacific Partners
CCEP
$46.5B
$401K ﹤0.01%
8,770
+248
+3% +$11.5K
AXTA icon
1464
Axalta
AXTA
$7.01B
$400K ﹤0.01%
17,190
-148
-0.9% -$3.68K
IXC icon
1465
iShares Global Energy ETF
IXC
$2.71B
$400K ﹤0.01%
+13,659
New +$460K
GGM
1466
DELISTED
GUGGENHEIM CREDIT ALLOCATION FUND
GGM
$400K ﹤0.01%
21,770
DLB icon
1467
Dolby
DLB
$4.72B
$399K ﹤0.01%
6,551
+201
+3% +$13.5K
GCC icon
1468
WisdomTree Enhanced Commodity Strategy Fund
GCC
$272M
$396K ﹤0.01%
+22,535
New +$410K
GDV icon
1469
Gabelli Dividend & Income Trust
GDV
$2.6B
$395K ﹤0.01%
21,549
-228
-1% -$4.72K
CYBR
1470
DELISTED
CyberArk
CYBR
$392K ﹤0.01%
+5,300
New +$379K
BXMT icon
1471
Blackstone Mortgage Trust
BXMT
$2.82B
$391K ﹤0.01%
12,263
+2,309
+23% +$78.2K
ELME
1472
Elme Communities
ELME
$132M
$391K ﹤0.01%
16,926
-6
-0% -$165
TOL icon
1473
Toll Brothers
TOL
$14B
$391K ﹤0.01%
11,849
+1,121
+10% +$36K
FWRD icon
1474
Forward Air
FWRD
$482M
$390K ﹤0.01%
+7,139
New +$439K
AOA icon
1475
iShares Core 80/20 Aggressive Allocation ETF
AOA
$3.16B
$387K ﹤0.01%
7,956
-422
-5% -$21.6K

Similar funds

HighTower Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, HighTower Advisors held 2,478 positions worth $13B, down 6% from $13.9B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

HighTower Advisors deployed $1.04B of net new capital in Q4 2018, opening 199 new positions and adding to 850 existing holdings. Its largest new stake was Invesco Large Cap Value ETF: 575,329 shares worth $18.8M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 11% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Schwab International Equity ETF, an estimated $41.4M trimmed.

  • HighTower Advisors's largest Q4 2018 buy was Invesco Large Cap Value ETF: 575,329 shares worth $18.8M.
  • HighTower Advisors added most to ExxonMobil in Q4 2018, an estimated $325M increase.
  • HighTower Advisors's biggest Q4 2018 reduction was Schwab International Equity ETF, cutting an estimated $41.4M.
  • HighTower Advisors fully exited State Street SPDR S&P Pharmaceuticals ETF in Q4 2018, selling an estimated $15.9M.
  • HighTower Advisors's ten largest holdings make up 17% of its $13B portfolio in Q4 2018.
  • HighTower Advisors opened 199 new positions and closed 277 in Q4 2018.
  • HighTower Advisors's portfolio value fell 6% quarter-over-quarter to $13B.

Based on HighTower Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.